Yokota S, Kumano K, Sakai T
Kidney Center, Sagamidai Hospital, Kanagawa, Japan.
Adv Perit Dial. 1997;13:221-3.
Sclerosing encapsulating peritonitis (SEP) is a very serious complication of CAPD. The present study was conducted on 7 SEP patients (4 male, 3 female, average age 33 years) from among 197 continuous ambulatory peritoneal dialysis (CAPD) patients over a period of 14 years. SEP affected 3.7% (7/197) of the CAPD patients in this study, and its annual incidence was found to be 2.6/1000. All 7 patients in this study exhibited ileus. The 3 patients with severe peritonitis and sepsis had transient ileus. The prognosis was poor for 3 patients who reported prior ultrafiltration problems. One of these patients died one year after the onset of SEP. The prognosis for one of the patients showed an intermediate course. SEP patients may possibly be divided into subgroups based on the course of prognosis. SEP patients with previous UF failure and longer duration of CAPD showed poorer prognoses. The quality of life, especially in regard to eating, is poor.
硬化性包裹性腹膜炎（SEP）是持续性非卧床腹膜透析（CAPD）的一种非常严重的并发症。本研究对197例接受CAPD治疗长达14年的患者中的7例SEP患者（4例男性，3例女性，平均年龄33岁）进行。在本研究中，SEP影响了3.7%（7/197）的CAPD患者，其年发病率为2.6/1000。本研究中的所有7例患者均出现肠梗阻。3例患有严重腹膜炎和败血症的患者出现了短暂性肠梗阻。3例曾有超滤问题的患者预后较差。其中1例患者在SEP发病一年后死亡。1例患者的预后呈中间病程。SEP患者可能根据预后过程分为亚组。既往超滤失败且CAPD治疗时间较长的SEP患者预后较差。生活质量，尤其是饮食方面的生活质量较差。
